Sirnaomics
Nigel has 12+ years of transaction experiences in merger & acquisitions, initial public offerings, and private equity. Prior to joining Sirnaomics, Nigel served as a vice president in the Credit Suisse’ investment banking team, and later transferred to Credit Suisse’ private equity team covering growth equity opportunities across healthcare, consumer, and technology sectors in Asia Pacific. In his current role, Nigel manages the overall fundraising process of the group and communication with the banking and investor communities.
This person is not in any offices
Sirnaomics
1 followers
Sirnaomics is a clinical stage biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human disorders with unmet medical needs.